Parameters relating to subject and physician satisfaction, the time interval between doses administered (duration between treatment cycles), dosages used, and adverse effects experienced were investigated.
Predictors of an incomplete colonoscopy were investigated by multivariate stepwise (p-entry = 0.15) logistic regression analysis, including sex, age, body weight, ASA category, total dosage of propofol administered, duration of the procedure, endoscopists' experience levels, bowel preparation, and any AAI as predictors.
This retrospective study, comparing use of botulinum toxin type A preparations in daily clinical practice, analyzed subject and physician satisfaction, the time interval between doses administered (duration between treatment cycles), dosages used, and adverse effects experienced, and found no differences between incobotulinumtoxinA and onabotulinumtoxinA.
The antimicrobial treatment regimen was recorded, including the agent or agents administered, the duration of treatment, and clinical response.
Examples include the number of previously administered therapies, duration of response, remaining systemic treatment options, bone marrow function, weight loss etc.
It is believed that 25 50% of all prescribed antibiotics are inappropriate in respect of drug choice, dose administered or duration of treatment [ 2].
Data collection included the authors' names, year of publication, number of subjects included in the study, types of EN administered, treatment duration, length of follow-up, remission and response rates, and adverse effects.
Given are number of infants receiving each intervention (n), the total time the intervention was administered (Total duration, given as median and range of all analyzed recordings) and the percentage of time spent for the intervention compared to total analyzed time (Relative duration, given as median and range of all recordings).
However, the therapeutic regimens (e.g. types of agents administered and duration of administration) used by our study subjects varied greatly and we were not able to include such a wide range of parameters in the multivariate regression model, because the number of observed CVE was insufficient.
These studies all differ in the dose intensity of carboplatin and paclitaxel administered, the duration of dose-dense therapy and the concurrent toxicity (Bolanos et al, 2001; Katsumata et al, 2001; Dunton, 2003; Havrilesky et al, 2003; Van der Burg et al, 2004; Kikuchi et al, 2005; Rose et al, 2005; Watanabe et al, 2005; Cadron et al, 2007).
